$2.80
-0.0444[-1.56%]
At close: May 8
$2.80
0[0.00%]
PreMarket: 7:53AM EDT
Lisata Therapeutics
(NASDAQ:LSTA)Lisata Therapeutics Stock (NASDAQ:LSTA), Analyst Ratings, Price Targets, Predictions
Lisata Therapeutics Inc has a consensus price target of $15, established from looking at the 8 latest analyst ratings. The last 3 analyst ratings were released from HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co. on April 26, 2024, April 25, 2024, and March 1, 2024. With an average price target of $15 between HC Wainwright & Co., HC Wainwright & Co., and HC Wainwright & Co., there's an implied 435.71% upside for Lisata Therapeutics Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Lisata Therapeutics
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 04/26/2024 | Buy Now | 435.71% | HC Wainwright & Co. | Joseph Pantginis | → $15 | Reiterates | Buy → Buy | Get Alert |
| 04/25/2024 | Buy Now | 435.71% | HC Wainwright & Co. | Joseph Pantginis | → $15 | Reiterates | Buy → Buy | Get Alert |
| 03/01/2024 | Buy Now | 435.71% | HC Wainwright & Co. | Joseph Pantginis | → $15 | Reiterates | Buy → Buy | Get Alert |
| 01/04/2024 | Buy Now | 435.71% | HC Wainwright & Co. | Joseph Pantginis | → $15 | Reiterates | Buy → Buy | Get Alert |
| 08/15/2023 | Buy Now | 435.71% | HC Wainwright & Co. | Joseph Pantginis | → $15 | Reiterates | Buy → Buy | Get Alert |
| 05/25/2023 | Buy Now | 435.71% | HC Wainwright & Co. | Joseph Pantginis | → $15 | Reiterates | Buy → Buy | Get Alert |
| 03/31/2023 | Buy Now | 435.71% | HC Wainwright & Co. | Joseph Pantginis | → $15 | Reiterates | → Buy | Get Alert |
| 10/19/2022 | Buy Now | 435.71% | HC Wainwright & Co. | Joseph Pantginis | $6 → $15 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Lisata Therapeutics (LSTA)?
The latest price target for Lisata Therapeutics (NASDAQ: LSTA) was reported by HC Wainwright & Co. on April 26, 2024. The analyst firm set a price target for $15.00 expecting LSTA to rise to within 12 months (a possible 435.71% upside). 6 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Lisata Therapeutics (LSTA)?
The latest analyst rating for Lisata Therapeutics (NASDAQ: LSTA) was provided by HC Wainwright & Co., and Lisata Therapeutics reiterated their buy rating.
When was the last upgrade for Lisata Therapeutics (LSTA)?
There is no last upgrade for Lisata Therapeutics.
When was the last downgrade for Lisata Therapeutics (LSTA)?
There is no last downgrade for Lisata Therapeutics.
When is the next analyst rating going to be posted or updated for Lisata Therapeutics (LSTA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Lisata Therapeutics, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Lisata Therapeutics was filed on April 26, 2024 so you should expect the next rating to be made available sometime around April 26, 2025.
Is the Analyst Rating Lisata Therapeutics (LSTA) correct?
While ratings are subjective and will change, the latest Lisata Therapeutics (LSTA) rating was a reiterated with a price target of $0.00 to $15.00. The current price Lisata Therapeutics (LSTA) is trading at is $2.80, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.